{"id":9463,"date":"2002-12-01T19:12:06","date_gmt":"2002-12-01T19:12:06","guid":{"rendered":"http:\/\/i-base.info\/htb\/?p=9463"},"modified":"2014-06-03T17:28:00","modified_gmt":"2014-06-03T17:28:00","slug":"post-meeting-coverage-of-the-42nd-icaac","status":"publish","type":"post","link":"https:\/\/i-base.info\/htb\/9463","title":{"rendered":"Post-meeting coverage of the 42nd ICAAC"},"content":{"rendered":"<p><strong>New post-meeting coverage now available, certified for CME. Topics include first-line antiretroviral therapy, treatment-experienced patients, adverse events, and opportunistic infections.<\/strong><\/p>\n<p>Medscape HIV\/AIDS, 2002<br \/>\n<strong><br \/>\nFirst-line antiretroviral therapy: new challenges to efavirenz\u2019s supremacy?<\/strong><br \/>\nJoseph J Eron Jr MD<br \/>\n<a href=\"http:\/\/www.medscape.com\/viewarticle\/443382\">http:\/\/www.medscape.com\/viewarticle\/443382<\/a><\/p>\n<p>Management of treatment-experienced patients<br \/>\nDaniel Kuritzkes MD<br \/>\n<a href=\"http:\/\/www.medscape.com\/viewarticle\/443383\">http:\/\/www.medscape.com\/viewarticle\/443383<\/a><\/p>\n<p><strong>Opportunistic infections and coinfections in HIV-infected patients<\/strong><br \/>\nHenry Masur MD<br \/>\n<a href=\"http:\/\/www.medscape.com\/viewarticle\/443384\">http:\/\/www.medscape.com\/viewarticle\/443384<\/a><\/p>\n<p><strong>Adverse effects of antiretrovirals: focus on hyperlactatemia and Hepatotoxicity<\/strong><br \/>\nWilliam G Powderly MD<br \/>\n<a href=\"http:\/\/www.medscape.com\/viewarticle\/443385\">http:\/\/www.medscape.com\/viewarticle\/443385<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>New post-meeting coverage now available, certified for CME. Topics include first-line antiretroviral therapy, treatment-experienced patients, adverse events, and opportunistic infections. Medscape HIV\/AIDS, 2002 First-line antiretroviral therapy: new challenges to efavirenz\u2019s supremacy? Joseph J Eron Jr MD http:\/\/www.medscape.com\/viewarticle\/443382 Management of treatment-experienced &hellip;<\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[30],"tags":[],"class_list":["post-9463","post","type-post","status-publish","format-standard","hentry","category-on-the-web"],"_links":{"self":[{"href":"https:\/\/i-base.info\/htb\/wp-json\/wp\/v2\/posts\/9463","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/i-base.info\/htb\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/i-base.info\/htb\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/i-base.info\/htb\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/i-base.info\/htb\/wp-json\/wp\/v2\/comments?post=9463"}],"version-history":[{"count":0,"href":"https:\/\/i-base.info\/htb\/wp-json\/wp\/v2\/posts\/9463\/revisions"}],"wp:attachment":[{"href":"https:\/\/i-base.info\/htb\/wp-json\/wp\/v2\/media?parent=9463"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/i-base.info\/htb\/wp-json\/wp\/v2\/categories?post=9463"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/i-base.info\/htb\/wp-json\/wp\/v2\/tags?post=9463"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}